Is sapropterin sufficient to eradicate all pku symptoms?

Does sapropterin eliminate every PKU symptom?

Sapropterin is a synthetic form of tetrahydrobiopterin that helps some people with phenylketonuria (PKU) lower phenylalanine levels. It works only in patients who respond to the drug, and even in responders it rarely brings phenylalanine down to the normal range without continued dietary phenylalanine restriction.

What happens if sapropterin fails to lower levels enough?

Patients who do not respond or who still have elevated phenylalanine must keep using the low-phenylalanine diet indefinitely. Without that combination, cognitive impairment, behavioral issues, and neurological damage can still develop or worsen.

How long does sapropterin work?

The drug requires daily dosing and its effect lasts only while taken. Stopping sapropterin causes phenylalanine to rise again within days. Long-term studies show sustained phenylalanine reductions in responders but no cure.

Can sapropterin replace the diet entirely?

No clinical evidence shows sapropterin alone suffices for any PKU patient. Guidelines recommend keeping dietary therapy alongside sapropterin in all responders. A few patients achieve target levels on medication alone, but these cases are rare and require close monitoring.

Why are companies challenging related patents?

Patents covering formulations and uses of sapropterin have faced challenges from generic manufacturers seeking to enter the market earlier. [1]

What side effects are patients asking about?

Common concerns include headache, runny nose, and upper respiratory infections. Serious adverse events are rare but include hypersensitivity reactions. Patients also fear long-term neurological outcomes if phenylalanine remains above target.

When does exclusivity expire?

Exclusivity for certain sapropterin formulations expires in the US in 2025. Generic versions may become available once patents clear. [1]

Who makes sapropterin?

BioMarin produces the branded version Kuvan. Generic versions are now available in some markets from competitors such as Par Pharmaceutical.